Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7144-7155

  Köröskényi, Krisztina ^a   Duró, Edina ^a   Pallai, Anna ^a   Sarang, Zsolt ^a   Kloor, Doris ^b   Ucker, David S ^c   Beceiro, Susana ^d   Castrillo, Antonio ^e   Chawla, Ajay ^f   Ledent, Catherine A ^g   Fésüs, László ^a   Szondy, Zsuzsa ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^e INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; LIVER X RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; ANIMAL; IMMUNOLOGY; MACROPHAGE; MOUSE MUTANT; PATHOLOGY; PERITONITIS; PHAGOCYTOSIS;

ADENOSINE; ANIMALS; APOPTOSIS; INFLAMMATION; MACROPHAGES; MICE; MICE, KNOCKOUT; PERITONITIS; PHAGOCYTOSIS; RECEPTOR, ADENOSINE A2A;

EID: 79959564391     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002284     Document Type: Article

References (47)

1. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14: 131-136. (Pubitemid 23068298)
2. Gregory, C. D., and A. Devitt. 2004. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113: 1-14.
3. Munoz, L. E., U. S. Gaipl, S. Franz, A. Sheriff, R. E. Voll, J. R. Kalden, and M. Herrmann. 2005. SLE - a disease of clearance deficiency? Rheumatology (Oxford) 44: 1101-1107.
4. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
5. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101: 890-898. (Pubitemid 28096086)
6. Cvetanovic, M., and D. S. Ucker. 2004. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J. Immunol. 172: 880-889.
7. Cocco, R. E., and D. S. Ucker. 2001. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol. Biol. Cell 12: 919-930.
8. Patel, V. A., A. Longacre-Antoni, M. Cvetanovic, D. J. Lee, L. Feng, H. Fan, J. Rauch, D. S. Ucker, and J. S. Levine. 2007. The affirmative response of the innate immune system to apoptotic cells. Autoimmunity 40: 274-280.
9. Kim, S., K. B. Elkon, and X. Ma. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21: 643-653. (Pubitemid 39487888)
10. McDonald, P. P., V. A. Fadok, D. Bratton, and P. M. Henson. 1999. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-b in macrophages that have ingested apoptotic cells. J. Immunol. 163: 6164-6172.
11. Ralevic, V., and G. Burnstock. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50: 413-492.
12. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53: 527-552.
13. Haskó, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39.
14. Martin, C., M. Leone, X. Viviand, M. L. Ayem, and R. Guieu. 2000. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit. Care Med. 28: 3198-3202.
15. Sottofattori, E., M. Anzaldi, and L. Ottonello. 2001. HPLC determination of adenosine in human synovial fluid. J. Pharm. Biomed. Anal. 24: 1143-1146.
16. Ledent, C., J. M. Vaugeois, S. N. Schiffmann, T. Pedrazzini, M. El Yacoubi, J. J. Vanderhaeghen, J. Costentin, J. K. Heath, G. Vassart, and M. Parmentier. 1997. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388: 674-678. (Pubitemid 27366438)
17. Mukundan, L., J. I. Odegaard, C. R. Morel, J. E. Heredia, J. W. Mwangi, R. R. Ricardo-Gonzalez, Y. P. Goh, A. R. Eagle, S. E. Dunn, J. U. Awakuni, et al. 2009. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat. Med. 15: 1266-1272.
18. A-Gonzalez, N., S. J. Bensinger, C. Hong, S. Beceiro, M. N. Bradley, N. Zelcer, J. Deniz, C. Ramirez, M. Díaz, G. Gallardo, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31: 245-258.
19. Chen, G. Q., X. G. Shi, W. Tang, S. M. Xiong, J. Zhu, X. Cai, Z. G. Han, J. H. Ni, G. Y. Shi, P. M. Jia, et al. 1997. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89: 3345-3353.
20. Delabar, U., D. Kloor, G. Luippold, and B. Mühlbauer. 1999. Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 724: 231-238.
21. Kleinbongard, P., T. Rassaf, A. Dejam, S. Kerber, and M. Kelm. 2002. Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol. 359: 158-168. (Pubitemid 35387018)
22. Hoffmann, P. R., A. M. deCathelineau, C. A. Ogden, Y. Leverrier, D. L. Bratton, D. L. Daleke, A. J. Ridley, V. A. Fadok, and P. M. Henson. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155: 649-659.
23. Neville, L. F., G. Mathiak, and O. Bagasra. 1997. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev. 8: 207-219. (Pubitemid 28077928)
24. Iida, N., and G. R. Grotendorst. 1990. Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Mol. Cell. Biol. 10: 5596-5599.
25. Wolpe, S. D., B. Sherry, D. Juers, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86: 612-616.
26. Wolpe, S. D., and A. Cerami. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3: 2565-2573. (Pubitemid 20013270)
27. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476. (Pubitemid 39370503)
28. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8: 1314-1325.
29. Yang, Y. C., A. B. Ciarletta, P. A. Temple, M. P. Chung, S. Kovacic, J. S. Witek- Giannotti, A. C. Leary, R. Kriz, R. E. Donahue, G. G. Wong, et al. 1986. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 47: 3-10.
30. Cassel, D., and Z. Selinger. 1977. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. USA 74: 3307-3311.
31. Seamon, K. B., W. Padgett, and J. W. Daly. 1981. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA 78: 3363-3367.
32. Van Haastert, P. J., R. Van Driel, B. Jastorff, J. Baraniak, W. J. Stec, and R. J. De Wit. 1984. Competitive cAMP antagonists for cAMP-receptor proteins. J. Biol. Chem. 259: 10020-10024.
33. Shibata, T., K. Nagata, and Y. Kobayashi. 2006. A suppressive role of nitric oxide in MIP-2 production by macrophages upon coculturing with apoptotic cells. J. Leukoc. Biol. 80: 744-752.
34. Walpen, S., K. F. Beck, L. Schaefer, I. Raslik, W. Eberhardt, R. M. Schaefer, and J. Pfeilschifter. 2001. Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J. 15: 571-573.
35. Skidgel, R. A., X. P. Gao, V. Brovkovych, A. Rahman, D. Jho, S. Predescu, T. J. Standiford, and A. B. Malik. 2002. Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. J. Immunol. 169: 2093-2101.
36. Peranzoni, E., I. Marigo, L. Dolcetti, S. Ugel, N. Sonda, E. Taschin, B. Mantelli, V. Bronte, and P. Zanovello. 2007. Role of arginine metabolism in immunity and immunopathology. Immunobiology 212: 795-812.
37. Serhan, C. N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6: 1191-1197.
38. Rossi, A. G., J. C. McCutcheon, N. Roy, E. R. Chilvers, C. Haslett, and I. Dransfield. 1998. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. J. Immunol. 160: 3562-3568. (Pubitemid 28164752)
39. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
40. Khoa, N. D., M. C. Montesinos, A. B. Reiss, D. Delano, N. Awadallah, and B. N. Cronstein. 2001. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J. Immunol. 167: 4026-4032.
41. Montesinos, M. C., A. Desai, and B. N. Cronstein. 2006. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Arthritis Res. Ther. 8: R53.
42. Boutard, V., R. Havouis, B. Fouqueray, C. Philippe, J. P. Moulinoux, and L. Baud. 1995. Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J. Immunol. 155: 2077-2084.
43. Bredt, D. S., C. D. Ferris, and S. H. Snyder. 1992. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267: 10976-10981.
44. Freire-de-Lima, C. G., D. O. Nascimento, M. B. Soares, P. T. Bozza, H. C. Castro-Faria-Neto, F. G. de Mello, G. A. DosReis, and M. F. Lopes. 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199-203.
45. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178: 605-613.
46. Corraliza, I. M., M. Modolell, E. Ferber, and G. Soler. 1997. Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages. Biochim. Biophys. Acta 1334: 123-128.
47. Galea, E., and D. L. Feinstein. 1999. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 13: 2125-2137.